Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection
Bing Xu(Mayo Clinic in Arizona), Wuqiang Zhu(WinnMed), Jyotsna Joshi(Mayo Clinic in Arizona), Aaron Yang(Mayo Clinic in Arizona), Yajuan Su(University of Nebraska Medical Center), Shu Wang(Jiangnan University), Fan Li(Wenzhou Medical University), Wenjing Zhang(Ningxia Medical University), Dong Li(Children's Hospital of Philadelphia), Zhao Wang(Capital Medical University), Ling Tang(Mayo Clinic in Arizona), Haiwei Gu(Arizona State University), Pengsheng Li(Mayo Clinic in Arizona), Jingwei Xie(University of Nebraska–Lincoln)
Cited by 8
Related Papers
Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
|Advanced Science|2023|545
Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell–Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine
|Circulation|2017|469
Recent Advances in Electrospun Nanofibers for Wound Healing
|Nanomedicine|2017|398
Electrospinning: An enabling nanotechnology platform for drug delivery and regenerative medicine
|Advanced Drug Delivery Reviews|2018|378